Furthermore, we ran the same analysis on the combination of KAI1 and p27, and found loss of both proteins better differentiated metastatic from primary melanomas, suggesting that double loss of both KAI1 and p27 can serve as a potential signature for metastatic like (ML) primary melanomas. This evidence concerns the gene CD82 and melanoma.